Peter Salmi

2.1k total citations
44 papers, 1.7k citations indexed

About

Peter Salmi is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Social Psychology. According to data from OpenAlex, Peter Salmi has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 11 papers in Social Psychology. Recurrent topics in Peter Salmi's work include Neurotransmitter Receptor Influence on Behavior (19 papers), Neuroscience and Neuropharmacology Research (12 papers) and Neuroendocrine regulation and behavior (11 papers). Peter Salmi is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (19 papers), Neuroscience and Neuropharmacology Research (12 papers) and Neuroendocrine regulation and behavior (11 papers). Peter Salmi collaborates with scholars based in Sweden, Denmark and Germany. Peter Salmi's co-authors include Sven Ahlénius, Claes Wahlestedt, Johanna Kela, Tomas Hökfelt, Michael H. Ossipov, Josephine Lai, Frank Porreca, Jan Skouv, Liam Good and Jesper Wengel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Brain Research.

In The Last Decade

Peter Salmi

43 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Salmi Sweden 23 773 545 266 181 147 44 1.7k
Kay Marshall United Kingdom 20 329 0.4× 232 0.4× 163 0.6× 246 1.4× 129 0.9× 64 1.5k
Yung-yu Huang United States 14 480 0.6× 569 1.0× 276 1.0× 191 1.1× 121 0.8× 21 1.6k
David J. Watson United States 20 720 0.9× 867 1.6× 193 0.7× 385 2.1× 203 1.4× 47 2.7k
Fiona Bright Australia 15 596 0.8× 791 1.5× 141 0.5× 126 0.7× 152 1.0× 28 1.6k
Philippe A. Melas Sweden 18 564 0.7× 195 0.4× 181 0.7× 189 1.0× 136 0.9× 35 1.3k
Éva Keller Hungary 27 609 0.8× 531 1.0× 115 0.4× 226 1.2× 218 1.5× 76 2.4k
Katherine Beebe United States 17 372 0.5× 400 0.7× 160 0.6× 308 1.7× 55 0.4× 28 2.0k
Shigeto Yamada Japan 20 405 0.5× 436 0.8× 257 1.0× 70 0.4× 123 0.8× 91 1.5k
Enrique Echevarrı́a Spain 20 380 0.5× 283 0.5× 99 0.4× 86 0.5× 54 0.4× 85 1.2k
Koki Ito Japan 19 396 0.5× 411 0.8× 195 0.7× 78 0.4× 85 0.6× 65 1.2k

Countries citing papers authored by Peter Salmi

Since Specialization
Citations

This map shows the geographic impact of Peter Salmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Salmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Salmi more than expected).

Fields of papers citing papers by Peter Salmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Salmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Salmi. The network helps show where Peter Salmi may publish in the future.

Co-authorship network of co-authors of Peter Salmi

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Salmi. A scholar is included among the top collaborators of Peter Salmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Salmi. Peter Salmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berlin, Marie, et al.. (2020). Depressioner och ångestsyndrom bland barn och unga förknippade med långsiktiga konsekvenser – en nationell registerstudie. Socialmedicinsk tidskrift. 97(5-6). 771–782. 1 indexed citations
2.
Salmi, Peter, Pia Svedberg, Jan Hagberg, et al.. (2008). Outcome of multidisciplinary investigations of long-term sickness absentees. Disability and Rehabilitation. 31(2). 131–137. 10 indexed citations
3.
Salmi, Peter, Sven Ove Ögren, Marie Vahter, et al.. (2007). The effects of methylmercury on motor activity are sex- and age-dependent, and modulated by genetic deletion of adenosine receptors and caffeine administration. Toxicology. 241(3). 119–133. 31 indexed citations
4.
Salmi, Peter, Karima Chergui, & Bertil B. Fredholm. (2005). Adenosine–Dopamine Interactions Revealed in Knockout Mice. Journal of Molecular Neuroscience. 26(2-3). 239–244. 35 indexed citations
5.
Salmi, Peter, Ruben Isacson, & Björn Kull. (2004). Dihydrexidine — The First Full Dopamine D1Receptor Agonist. CNS Drug Reviews. 10(3). 230–242. 38 indexed citations
6.
Ahlqvist, Jenny, Ruben Isacson, Claes Wahlestedt, & Peter Salmi. (2003). Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats. European Neuropsychopharmacology. 13(3). 177–182. 6 indexed citations
7.
Isacson, Ruben, Björn Kull, Peter Salmi, & Claes Wahlestedt. (2003). Lack of efficacy of ‘naked’ small interfering RNA applied directly to rat brain. Acta Physiologica Scandinavica. 179(2). 173–177. 26 indexed citations
8.
Salmi, Peter, Johanna Kela, Ulf Arvidsson, & Claes Wahlestedt. (2002). Functional interactions between δ- and μ-opioid receptors in rat thermoregulation. European Journal of Pharmacology. 458(1-2). 101–106. 22 indexed citations
9.
Salmi, Peter, et al.. (2000). Dopamine D2 receptor ribozyme inhibits quinpirole-induced stereotypy in rats. European Journal of Pharmacology. 388(1). R1–R2. 15 indexed citations
12.
Salmi, Peter & Sven Ahlénius. (1998). Evidence for Functional Interactions between 5‐HT1Aand 5‐HT2AReceptors in Rat Thermoregulatory Mechanisms. Pharmacology & Toxicology. 82(3). 122–127. 60 indexed citations
14.
Salmi, Peter & Sven Ahlénius. (1996). Further evidence for clozapine as a dopamine D1 receptor agonist. European Journal of Pharmacology. 307(1). 27–31. 40 indexed citations
16.
Ahlénius, Sven & Peter Salmi. (1994). Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat. European Journal of Pharmacology. 260(2-3). 177–181. 78 indexed citations
17.
Salmi, Peter, et al.. (1994). A new computer-assisted two-way avoidance conditioning equipment for rats: Behavioral and pharmacological validation. Journal of Pharmacological and Toxicological Methods. 32(3). 155–159. 25 indexed citations
18.
Salmi, Peter, et al.. (1994). Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat. European Journal of Pharmacology. 253(1-2). 67–73. 46 indexed citations
19.
Ahlénius, Sven, et al.. (1993). Effects of 5‐HT1A Receptor Agonists on Patterns of Rat Motor Activity in Relation to Effects on Forebrain Monoamine Synthesis. Pharmacology & Toxicology. 72(6). 398–406. 21 indexed citations
20.
Fredrikson, Mats, Timo Hursti, Peter Salmi, et al.. (1993). Conditioned nausea after cancer chemotherapy and autonomic nervous system conditionability. Scandinavian Journal of Psychology. 34(4). 318–327. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026